Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Progenity Inc (PROG)

Progenity Inc (PROG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 162,924
  • Shares Outstanding, K 184,199
  • Annual Sales, $ 1,250 K
  • Annual Income, $ -247,410 K
  • 60-Month Beta 1.03
  • Price/Sales 135.35
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PROG with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.80
  • Most Recent Earnings $-0.21 on 03/28/22
  • Latest Earnings Date 05/10/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/22
See More
  • Average Estimate -0.12
  • Number of Estimates 1
  • High Estimate -0.12
  • Low Estimate -0.12
  • Prior Year -0.56
  • Growth Rate Est. (year over year) +78.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7850 +12.68%
on 04/28/22
1.2000 -26.29%
on 04/07/22
-0.3255 (-26.90%)
since 04/06/22
3-Month
0.7850 +12.68%
on 04/28/22
2.1100 -58.08%
on 02/10/22
-0.6455 (-42.19%)
since 02/04/22
52-Week
0.6570 +34.63%
on 08/20/21
6.2000 -85.73%
on 11/17/21
-1.9755 (-69.07%)
since 05/06/21

Most Recent Stories

More News
Progenity Announces Successful Transfer of Liquid Biopsy Technologies

Enumera Molecular Formed to Develop and Commercialize Next-Generation Solutions for Liquid Biopsy...

PROG : 0.8845 (-3.47%)
Progenity Appoints Paul Shabram to Lead Technical Operations of the Company’s Ingestible Drug/Device Platforms

Expanding Leadership Team to Accelerate Development of Innovative Therapeutic Delivery Platforms...

PROG : 0.8845 (-3.47%)
Progenity to Become Biora Therapeutics as it Completes Transformation

Upcoming Change Reflects the Company’s Focus on Oral Delivery of Biotherapeutics...

PROG : 0.8845 (-3.47%)
Progenity Announces Two Poster Presentations at Controlled Release Society 2022

SAN DIEGO, April 06, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for...

PROG : 0.8845 (-3.47%)
U.S. Stock Indexes Jump on Cease-Fire Optimism in Ukraine

Morning Markets June S&P 500 futures this morning rallied to a 2-1/4 month high and are up by +0.87%. Stock indexes pushed higher this morning on optimism about progress in cease-fire talks between Russia...

BTBT : 2.87 (+14.80%)
JEF : 44.10 (-4.40%)
DNA : 1.1600 (+5.45%)
REYN : 28.56 (-0.73%)
CVS : 79.76 (+0.42%)
PLAY : 62.60 (+1.85%)
PROG : 0.8845 (-3.47%)
PINS : 34.67 (-0.60%)
ETSY : 68.72 (+1.07%)
Progenity Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

Accelerated Company Transformation Toward Oral Delivery of Biotherapeutics and Targeted Therapeutics Programs Progressed Company’s Targeted Therapeutics...

PROG : 0.8845 (-3.47%)
Interesting PROG Put And Call Options For May 20th

Investors in Progenity Inc saw new options begin trading this week, for the May 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PROG options chain for the...

PROG : 0.8845 (-3.47%)
Jobs Figures Due Friday in U.S.

Monday U.S. Featured Earnings Jefferies Financial Group Inc. (NYSE:JEF) (Q1) EPS estimates ...

LAS-A.TO : 148.76 (-2.13%)
MRV.TO : 1.35 (unch)
DLCG.TO : 3.00 (unch)
JEF : 44.10 (-4.40%)
SAIC : 130.39 (+0.24%)
PROG : 0.8845 (-3.47%)
MU : 117.89 (-1.14%)
LULU : 390.65 (+0.31%)
MKC : 76.81 (+1.03%)
PAYX : 122.80 (+1.05%)
AER : 86.91 (-0.78%)
WBA : 21.69 (+3.19%)
Progenity to Report Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update

SAN DIEGO, March 16, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for...

PROG : 0.8845 (-3.47%)
Progenity Progresses its Drug Delivery System Clinical Device Performance Studies

Clinical Device Performance Study in Healthy Volunteers Demonstrated Accurate Localization and Delivery A Clinical Device Performance Study in Patients...

PROG : 0.8845 (-3.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Biora Therapeutics Inc. is a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond. Biora Therapeutics Inc., formerly known as Progenity Inc., is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 1.0030
2nd Resistance Point 0.9615
1st Resistance Point 0.9230
Last Price 0.8845
1st Support Level 0.8430
2nd Support Level 0.8015
3rd Support Level 0.7630

See More

52-Week High 6.2000
Fibonacci 61.8% 4.0826
Fibonacci 50% 3.4285
Fibonacci 38.2% 2.7744
Last Price 0.8845
52-Week Low 0.6570

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar